MedTrace Logo

A Clinical Study of SHR8554 Injection for the Treatment of Pain After Abdominal Surgery.

NCT04766463 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 528

Last updated 2022-07-06

No results posted yet for this study

Summary

The primary objective is to evaluate the analgesic efficacy of IV SHR8554 compared with placebo and morphine in patients with acute postoperative pain following abdominal surgery

Conditions

Interventions

DRUG

SHR8554 Injection

SHR8554 Injection; high dose

DRUG

SHR8554 Injection

SHR8554 Injection; low dose

DRUG

Placebo

Saline Solution

DRUG

Morphine

Morphine

Sponsors & Collaborators

  • Jiangsu HengRui Medicine Co., Ltd.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-03-03
Primary Completion
2021-10-19
Completion
2021-11-01

Countries

  • China

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04766463 on ClinicalTrials.gov